与使用阿片类药物治疗慢性非癌症疼痛相关的种族和民族差异
Patrick I Oliorah1, Sujit S Sansgiry2
1College of Pharmacy, University of Houston, Houston, USA.
Cureus
|March 9, 2026
概括
在慢性非癌症疼痛 (CNCP) 治疗中,种族差异仍然存在. 与白人患者相比,黑人患者接受阿片类药物治疗的可能性较低,尽管CNCP的阿片类药物使用总体下降.
科学领域:
- 疼痛管理 疼痛管理
- 健康差异 在健康上的差异
- 公共卫生 公共卫生
背景情况:
- 慢性非癌症疼痛 (CNCP) 显著影响美国成年人,治疗通常涉及阿片类和非阿片类疗法.
- 国家战略旨在减少对CNCP的阿片类药物使用,但其跨种族群体的公平影响尚不清楚.
研究的目的:
- 调查阿片类药物使用中的种族和种族差异,以管理CNCP.
- 评估国家努力制阿片类药物处方是否同样影响所有种族群体.
主要方法:
- 一项连续的横截面研究利用了2016-2021年全国代表性的医疗支出小组调查 (MEPS) 数据.
- 在非西班牙裔白人,非西班牙裔黑人,亚洲人/其他人和西班牙裔人口中,对CNCP的阿片类和非阿片类治疗选择进行了比较.
主要成果:
- 总体而言,5.51%的CNCP患者使用阿片类药物治疗,而94.49%使用非阿片类药物治疗.
- 观察到显著的种族差异:与白人相比,黑人人使用阿片类药物的几率较低 (OR=0.759).
- 这些差异是显而易见的,尽管阿片类药物处方在CNCP的总体下降.
结论:
- 在CNCP治疗中使用阿片类药物的种族差异仍然存在.
- 与白人患者相比,黑人患者接受CNCP的阿片类药物治疗的可能性较小.
- 需要进一步的研究来理解和解决疼痛管理中的这些不平等问题.
相关概念视频
Analgesia and Pain Management
2.6K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.6K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.3K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.3K
Opioid Receptors: Overview
5.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.7K
Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Drug Toxicity: Risk factors
68
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
68


